Related Experiment Video
Updated: May 6, 2026
Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells
Published on: April 26, 2017
Alternative Pre-mRNA Splicing, Cell Death, and Cancer
Kong Ruirui1, Payal Ray, Mengxue Yang
1State Key Laboratory of Brain and Cognitive Science, Institute of Biophysics, Chinese Academy of Science, Beijing, China.
Abstract:
Alternative splicing is one of the most powerful mechanisms for generating functionally distinct products from a single genetic loci and for fine-tuning gene activities at the post-transcriptional level. Alternative splicing plays important roles in regulating genes critical for cell death. These cell death genes encode death ligands, cell surface death receptors, intracellular death regulators, signal transduction molecules, and death executor enzymes such as caspases and nucleases. Alternative splicing of these genes often leads to the formation of functionally different products, some of which have antagonistic effects that are either cell death-promoting or cell death-preventing. Differential alternative splicing can affect expression, subcellular distribution, and functional activities of the gene products. Molecular defects in splicing regulation of cell death genes have been associated with cancer development and resistance to treatment. Studies using molecular, biochemical, and systems-based approaches have begun to reveal mechanisms underlying the regulation of alternative splicing of cell death genes. Systematic studies have begun to uncover the multi-level interconnected networks that regulate alternative splicing. A global picture of the complex mechanisms that regulate cell death genes at the pre-mRNA splicing level has thus begun to emerge.
Insights
Alternative splicing fine-tunes gene activity and regulates cell death pathways. Dysregulation of this process in cell death genes is linked to cancer and treatment resistance.
Area of Science:
- Molecular Biology
- Genetics
- Cell Biology
Background:
- Alternative splicing generates diverse products from single genes, regulating gene activity post-transcriptionally.
- This process is crucial for genes involved in cell death, including ligands, receptors, regulators, and executioners like caspases.
- Aberrant splicing of cell death genes can lead to opposing effects (cell death-promoting or preventing) and impact gene expression and function.
Purpose of the Study:
- To explore the regulatory mechanisms of alternative splicing in cell death genes.
- To understand how differential splicing affects gene products' expression, localization, and activity.
- To investigate the link between splicing defects and diseases like cancer.
Main Methods:
- Molecular approaches
- Biochemical analyses
- Systems-based studies
Main Results:
- Alternative splicing produces functionally distinct, sometimes antagonistic, products from cell death genes.
- Splicing defects in these genes are associated with cancer development and therapeutic resistance.
- Studies are revealing complex, multi-level regulatory networks governing alternative splicing of cell death genes.
Conclusions:
- Alternative splicing is a key regulator of cell death pathways.
- Understanding these splicing mechanisms is vital for cancer research and treatment strategies.
- A comprehensive view of alternative splicing regulation in cell death genes is emerging.
Related Concept Videos
01:32RNA Splicing
01:32RNA Splicing
02:18Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
02:18Alternative RNA Splicing
02:01Pre-mRNA Processing
02:01pre-mRNA Processing
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a “cap” to the 5’ end of the growing transcript. In this process, a 5’ phosphate is replaced by modified guanosine that has a methyl group attached to it (7-Methyl...